{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T05:11:38Z","timestamp":1788671498936,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP220639"],"award-info":[{"award-number":["RP220639"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Blood Cancer United","doi-asserted-by":"publisher","award":["6681-24"],"award-info":[{"award-number":["6681-24"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018857","name":"International Myeloma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society Inc","doi-asserted-by":"publisher","award":["MBGI-24-1313934-01-MBG"],"award-info":[{"award-number":["MBGI-24-1313934-01-MBG"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.drup.2026.101436","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T15:49:30Z","timestamp":1781884170000},"page":"101436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["NHE6-driven endosome-autophagy axis confers proteasome inhibitor resistance in multiple myeloma"],"prefix":"10.1016","volume":"88","author":[{"given":"Liuting","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-hsing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2901-1763","authenticated-orcid":false,"given":"Yutong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5143-160X","authenticated-orcid":false,"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2026.101436_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076019","article-title":"Autophagy: a potential therapeutic target to tackle drug resistance in multiple myeloma","volume":"24","author":"Bashiri","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drup.2026.101436_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41419-022-04508-2","article-title":"Blocking autophagy overcomes resistance to dual histone deacetylase and proteasome inhibition in gynecologic cancer","volume":"13","author":"Bi","year":"2022","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.drup.2026.101436_bib3","first-page":"131","article-title":"IMiD resistance in multiple myeloma: current understanding of the underpinning biology and clinical impact","volume":"142","author":"Bird","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.drup.2026.101436_bib4","doi-asserted-by":"crossref","first-page":"C1031","DOI":"10.1152\/ajpcell.00420.2001","article-title":"Human Na(+)\/H(+) exchanger isoform 6 is found in recycling endosomes of cells, not in mitochondria","volume":"282","author":"Brett","year":"2002","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"10.1016\/j.drup.2026.101436_bib5","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.4049\/jimmunol.1103826","article-title":"Immune mechanism of the antitumor effects generated by bortezomib","volume":"189","author":"Chang","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.drup.2026.101436_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13045-020-01000-2","article-title":"Targeting autophagy to overcome drug resistance: further developments","volume":"13","author":"Chang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.drup.2026.101436_bib7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/leu.2017.329","article-title":"Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond","volume":"32","author":"Chim","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.drup.2026.101436_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(15)00464-7","article-title":"Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study","volume":"17","author":"Dimopoulos","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.drup.2026.101436_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41408-020-0311-8","volume":"10","author":"Durie","year":"2020","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.drup.2026.101436_bib10","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1182\/blood-2018-09-874396","article-title":"Carfilzomib or bortezomib with melphalan-prednisone for transplant-ineligible patients with newly diagnosed multiple myeloma","volume":"133","author":"Facon","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.drup.2026.101436_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105582","article-title":"Chloroquine and hydroxychloroquine in antitumor therapies based on autophagy-related mechanisms","volume":"168","author":"Ferreira","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.drup.2026.101436_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9041195","article-title":"Resistance Mechanisms Towards CD38-Directed Antibody Therapy in Multiple Myeloma","volume":"9","author":"Franssen","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.drup.2026.101436_bib13","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.15_suppl.8002","article-title":"Efficacy of carfilzomib lenalidomide dexamethasone (KRd) with or without transplantation in newly diagnosed myeloma according to risk status: Results from the FORTE trial","author":"Gay","year":"2019","journal-title":"Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.drup.2026.101436_bib14","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3324\/haematol.2020.247015","article-title":"Multiple myeloma: the (r)evolution of current therapy and a glance into future","volume":"105","author":"Gulla","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.drup.2026.101436_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1741-7007-9-39","article-title":"Following autophagy step by step","volume":"9","author":"Hansen","year":"2011","journal-title":"BMC Biol."},{"key":"10.1016\/j.drup.2026.101436_bib16","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1200\/JCO.2008.21.1060","article-title":"Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 Trials","volume":"27","author":"Harousseau","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2026.101436_bib17","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1091\/mbc.e16-03-0205","article-title":"The Ccz1-Mon1-Rab7 module and Rab5 control distinct steps of autophagy","volume":"27","author":"Hegedus","year":"2016","journal-title":"Mol. Biol. Cell."},{"key":"10.1016\/j.drup.2026.101436_bib18","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1158\/1535-7163.MCT-08-1177","article-title":"Effect of autophagy on multiple myeloma cell viability","volume":"8","author":"Hoang","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2026.101436_bib19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.bbamcr.2012.11.018","article-title":"Maturation of autophagosomes and endosomes: a key role for Rab7","volume":"1833","author":"Hyttinen","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drup.2026.101436_bib20","first-page":"192","article-title":"Impaired posttranslational processing and trafficking of an endosomal Na+\/H+ exchanger NHE6 mutant (Delta(370)WST(372)) associated with X-linked intellectual disability and autism, Neur","volume":"73","author":"Ilie","year":"2014","journal-title":"ochem Int."},{"key":"10.1016\/j.drup.2026.101436_bib21","doi-asserted-by":"crossref","first-page":"14034","DOI":"10.1038\/ncomms14034","article-title":"Architecture and mechanism of the late endosomal Rab7-like Ypt7 guanine nucleotide exchange factor complex Mon1-Ccz1","volume":"8","author":"Kiontke","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2026.101436_bib22","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10555-020-09870-1","article-title":"Emerging links between endosomal pH and cancer","volume":"39","author":"Ko","year":"2020","journal-title":"Cancer Metastas-.-. Rev."},{"key":"10.1016\/j.drup.2026.101436_bib23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.6004\/jnccn.2025.0023","article-title":"NCCN Guidelines\u00ae Insights: Multiple Myeloma, Version 1.2025: Featured Updates to the NCCN Guidelines\u00ae","volume":"23","author":"Kumar","year":"2025","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"10.1016\/j.drup.2026.101436_bib24","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S1470-2045(20)30452-6","volume":"21","author":"Kumar","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.drup.2026.101436_bib25","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"Kyle","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2026.101436_bib26","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jamaoncol.2021.0611","article-title":"Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma: The MANHATTAN Nonrandomized Clinical Trial","volume":"7","author":"Landgren","year":"2021","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.drup.2026.101436_bib27","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrc.2017.53","article-title":"Targeting autophagy in cancer","volume":"17","author":"Levy","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2026.101436_bib28","doi-asserted-by":"crossref","first-page":"15884","DOI":"10.1038\/ncomms15884","article-title":"Hypoxia-induced mobilization of NHE6 to the plasma membrane triggers endosome hyperacidification and chemoresistance","volume":"8","author":"Lucien","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2026.101436_bib29","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1080\/15548627.2018.1474314","article-title":"Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion","volume":"14","author":"Mauthe","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.drup.2026.101436_bib30","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1080\/15548627.2015.1066957","article-title":"Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A\/SERCA-dependent autophagosome-lysosome fusion","volume":"11","author":"Mauvezin","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.drup.2026.101436_bib31","doi-asserted-by":"crossref","first-page":"13503","DOI":"10.1074\/jbc.270.22.13503","article-title":"EEA1, an early endosome-associated protein. EEA1 is a conserved alpha-helical peripheral membrane protein flanked by cysteine \"fingers\" and contains a calmodulin-binding IQ motif","volume":"270","author":"Mu","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2026.101436_bib32","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1074\/jbc.M410041200","article-title":"Four Na+\/H+ exchanger isoforms are distributed to Golgi and post-Golgi compartments and are involved in organelle pH regulation","volume":"280","author":"Nakamura","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2026.101436_bib33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1083\/jcb.201702179","article-title":"pH of endophagosomes controls association of their membranes with Vps34 and PtdIns (3) P levels","volume":"217","author":"Naufer","year":"2018","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.drup.2026.101436_bib34","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.1074\/jbc.273.12.6951","article-title":"Identification of a mitochondrial Na+\/H+ exchanger","volume":"273","author":"Numata","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2026.101436_bib35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuron.2013.07.043","article-title":"Christianson syndrome protein NHE6 modulates TrkB endosomal signaling required for neuronal circuit development","volume":"80","author":"Ouyang","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.drup.2026.101436_bib36","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2026.101436_bib37","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.72034","article-title":"NHE6 depletion corrects ApoE4-mediated synaptic impairments and reduces amyloid plaque load","volume":"10","author":"Pohlkamp","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.drup.2026.101436_bib38","doi-asserted-by":"crossref","first-page":"E6640","DOI":"10.1073\/pnas.1801612115","article-title":"Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH","volume":"115","author":"Prasad","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2026.101436_bib39","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1074\/jbc.M114.602219","article-title":"The Na+\/H+ exchanger NHE6 modulates endosomal pH to control processing of amyloid precursor protein in a cell culture model of Alzheimer disease","volume":"290","author":"Prasad","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2026.101436_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev-cancerbio-041816-122338","article-title":"The Role of Autophagy in Cancer","volume":"1","author":"Santana-Codina","year":"2017","journal-title":"Annu. Rev. Cancer Biol."},{"key":"10.1016\/j.drup.2026.101436_bib41","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1038\/leu.2009.173","article-title":"Proteasome inhibitors in the treatment of multiple myeloma","volume":"23","author":"Shah","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.drup.2026.101436_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/jha2.1091","article-title":"Combined Proteasome and Autophagy Inhibition in Relapsed\/Refractory Multiple Myeloma\u2014A Phase I Trial of Hydroxychloroquine, Carfilzomib, and Dexamethasone","volume":"6","author":"Sl\u00f8rdahl","year":"2025","journal-title":"EJHaem"},{"key":"10.1016\/j.drup.2026.101436_bib43","series-title":"Probe Reports from the NIH Molecular Libraries Program","article-title":"Three small molecule pan activator families of Ras-related GTPases","author":"Surviladze","year":"2010"},{"key":"10.1016\/j.drup.2026.101436_bib44","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1242\/jcs.195057","article-title":"Ratiometric analysis of Acridine Orange staining in the study of acidic organelles and autophagy","volume":"129","author":"Thome","year":"2016","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.drup.2026.101436_bib45","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.7150\/thno.47996","article-title":"Endocytic pathway inhibition attenuates extracellular vesicle-induced reduction of chemosensitivity to bortezomib in multiple myeloma cells","volume":"11","author":"Tu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.drup.2026.101436_bib46","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","article-title":"Multiple myeloma","volume":"397","author":"van de Donk","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.drup.2026.101436_bib47","doi-asserted-by":"crossref","first-page":"12110","DOI":"10.1074\/jbc.M809277200","article-title":"Rab7 regulates late endocytic trafficking downstream of multivesicular body biogenesis and cargo sequestration","volume":"284","author":"Vanlandingham","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2026.101436_bib48","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.4161\/auto.29264","article-title":"Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed\/refractory myeloma","volume":"10","author":"Vogl","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.drup.2026.101436_bib49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/bjh.15210","article-title":"Resistance to proteasome inhibitors and other targeted therapies in myeloma","volume":"182","author":"Wallington-Beddoe","year":"2018","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.drup.2026.101436_bib50","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.40048","article-title":"Reversal of ApoE4-induced recycling block as a novel prevention approach for Alzheimer's disease","volume":"7","author":"Xian","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.drup.2026.101436_bib51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.leukres.2017.06.002","article-title":"Targeting autophagy in multiple myeloma","volume":"59","author":"Yun","year":"2017","journal-title":"Leuk. Res."},{"key":"10.1016\/j.drup.2026.101436_bib52","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1182\/blood.V99.5.1745","article-title":"Jr., Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells","volume":"99","author":"Zhan","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.drup.2026.101436_bib53","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ccell.2016.03.026","article-title":"Tight Junction Protein 1 modulates proteasome capacity and proteasome inhibitor sensitivity in multiple myeloma via EGFR\/JAK1\/STAT3 signaling","volume":"29","author":"Zhang","year":"2016","journal-title":"Cancer Cell."},{"key":"10.1016\/j.drup.2026.101436_bib54","doi-asserted-by":"crossref","unstructured":"K. Zhu, K. Dunner, Jr. and D.J. McConkey, Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells, Oncogene 29 (2010), pp. 451-462.","DOI":"10.1038\/onc.2009.343"}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:18:33Z","timestamp":1788668313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764626000877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":54,"alternative-id":["S1368764626000877"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2026.101436","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NHE6-driven endosome-autophagy axis confers proteasome inhibitor resistance in multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2026.101436","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101436"}}